ApoC-III Antisense Oligonucleotide Therapy Used in Glycogen Storage Disease Type 1a

Joseph Burns, V. Reid Sutton, Justin P. Zachariah

Open source

DOI
10.1016/j.jaccas.2026.109561
Published
2026-08
Container
JACC: Case Reports
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.jaccas.2026.109561,
  title = {ApoC-III Antisense Oligonucleotide Therapy Used in Glycogen Storage Disease Type 1a},
  author = {Joseph Burns and V. Reid Sutton and Justin P. Zachariah},
  year = {2026},
  journal = {JACC: Case Reports},
  doi = {10.1016/j.jaccas.2026.109561},
  url = {https://doi.org/10.1016/j.jaccas.2026.109561}
}

RIS

TY  - JOUR
TI  - ApoC-III Antisense Oligonucleotide Therapy Used in Glycogen Storage Disease Type 1a
AU  - Joseph Burns
AU  - V. Reid Sutton
AU  - Justin P. Zachariah
PY  - 2026
JO  - JACC: Case Reports
DO  - 10.1016/j.jaccas.2026.109561
UR  - https://doi.org/10.1016/j.jaccas.2026.109561
ER  - 

APA

Burns, J., Sutton, V. R., & Zachariah, J. P. (2026). ApoC-III Antisense Oligonucleotide Therapy Used in Glycogen Storage Disease Type 1a. JACC: Case Reports. https://doi.org/10.1016/j.jaccas.2026.109561

Source records